These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 15599912)
41. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316 [TBL] [Abstract][Full Text] [Related]
42. Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors. Di Fiore A; Pedone C; Antel J; Waldeck H; Witte A; Wurl M; Scozzafava A; Supuran CT; De Simone G Bioorg Med Chem Lett; 2008 Apr; 18(8):2669-74. PubMed ID: 18359629 [TBL] [Abstract][Full Text] [Related]
43. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II. Menchise V; De Simone G; Di Fiore A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2006 Dec; 16(24):6204-8. PubMed ID: 17000110 [TBL] [Abstract][Full Text] [Related]
44. Carbonic anhydrase inhibitors: the X-ray crystal structure of the adduct of N-hydroxysulfamide with isozyme II explains why this new zinc binding function is effective in the design of potent inhibitors. Temperini C; Winum JY; Montero JL; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2007 May; 17(10):2795-801. PubMed ID: 17346964 [TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety. Ghorab MM; Ragab FA; Hamed MM Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022 [TBL] [Abstract][Full Text] [Related]
46. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies. Güzel O; Temperini C; Innocenti A; Scozzafava A; Salman A; Supuran CT Bioorg Med Chem Lett; 2008 Jan; 18(1):152-8. PubMed ID: 18024029 [TBL] [Abstract][Full Text] [Related]
47. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Sentürk M; Gülçin I; Daştan A; Küfrevioğlu OI; Supuran CT Bioorg Med Chem; 2009 Apr; 17(8):3207-11. PubMed ID: 19231207 [TBL] [Abstract][Full Text] [Related]
48. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides. Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998 [TBL] [Abstract][Full Text] [Related]
49. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides. Maresca A; Carta F; Vullo D; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2009 Sep; 19(17):4929-32. PubMed ID: 19651511 [TBL] [Abstract][Full Text] [Related]
50. QSAR study on benzenesulphonamide carbonic anhydrase inhibitors: topological approach using Balaban index. Thakur A; Thakur M; Khadikar PV; Supuran CT; Sudele P Bioorg Med Chem; 2004 Feb; 12(4):789-93. PubMed ID: 14759739 [TBL] [Abstract][Full Text] [Related]
51. Protein crystal structures with ferrocene and ruthenocene-based enzyme inhibitors. Salmon AJ; Williams ML; Hofmann A; Poulsen SA Chem Commun (Camb); 2012 Feb; 48(17):2328-30. PubMed ID: 22258283 [TBL] [Abstract][Full Text] [Related]
52. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335 [TBL] [Abstract][Full Text] [Related]
53. Topological modeling of lipophilicity, diuretic activity, and carbonic inhibition activity of benzene sulfonamides: a molecular connectivity approach. Jaiswal M; Khadikar PV; Supuran CT Bioorg Med Chem Lett; 2004 Nov; 14(22):5661-6. PubMed ID: 15482943 [TBL] [Abstract][Full Text] [Related]
54. A DFT-based quantum theoretic QSAR study of aromatic and heterocyclic sulfonamides as carbonic anhydrase inhibitors against isozyme, CA-II. Eroglu E; Türkmen H J Mol Graph Model; 2007 Nov; 26(4):701-8. PubMed ID: 17493855 [TBL] [Abstract][Full Text] [Related]
56. Stereo- and regioselective azide/alkyne cycloadditions in carbonic anhydrase II via tethering, monitored by crystallography and mass spectrometry. Wischeler JS; Sun D; Sandner NU; Linne U; Heine A; Koert U; Klebe G Chemistry; 2011 May; 17(21):5842-51. PubMed ID: 21506176 [TBL] [Abstract][Full Text] [Related]
57. Synthesis of alpha-fluoro- and alpha,alpha-difluoro-benzenemethanesulfonamides: new inhibitors of carbonic anhydrase. Blackburn GM; Türkmen H Org Biomol Chem; 2005 Jan; 3(2):225-6. PubMed ID: 15632963 [TBL] [Abstract][Full Text] [Related]